Aurobindo Pharma USA will acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.

Aurobindo Pharma to acquire US-based Lannett for $250M, gaining a strategic local manufacturing base to offset tariffs and ...

Aurobindo Pharma USA acquires Lannett Company LLC for $250 million, expanding U.S. manufacturing capabilities and product ...

Hyderabad: In a major strategic move, Aurobindo Pharma Limited has announced that its wholly owned subsidiary, Aurobindo ...

The deal is being carried out on a cash-free, debt-free basis, factoring in standardised working capital levels.

Lannett CEO Arthur Bedrosian has slammed Shkreli. Yet his company boosted the cost of fluphenazine, which treats certain kinds of schizophrenia, to a net price of $195.53 from $11.17 between April ...

Lannett Company, Inc. (Nasdaq: LCI) is a pure play generic drug manufacturer based in Philadelphia. It has a diversified portfolio of generic drugs including over 100 marketed products and 250 SKUs.

Lannett cannot possibly sustain their Levo supply agreement at current terms. This distribution deal, which expires in 2019, will either fall due to price fixing, or be dramatically repriced.

Lannett is selling its liquid drug manufacturing facility in Carmel, N.Y., as well as equipment located at the facility, certain ANDAs and other assets to a private company for $10.5 million in ...

Lannett’s stock dropped 26.6% on Thursday, more than any other company that has told investors about the price collusion probe, including Endo International, Mylan and Teva Pharmaceuticals.

The biological medicine under development is a fast-acting insulin product. Lannett initiates human testing of biosimilar insulin product Philadelphia generic drug maker cutting 8.5% of workforce ...

Shares in Lannett Co. plunged 55% Monday after the generic-pharmaceuticals maker said a distribution pact with a key supplier won’t be renewed next year and that it would expand restructuring ...